Beam Therapeutics Inc.
BEAM stock score: 39/100
$24.56 · -1.13% · Scored Oct 22, 2026
- Technical
- 38
- Fundamental
- 40
- News
- 53
The reading
Beam Therapeutics (BEAM) scores 39 out of 100, which reads bearish, higher than 31% of Healthcare stocks and 16% of the 4,161 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 38, fundamentals 40.
Among the fundamentals, Fair Value at 100 and Quick Ratio at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 34 and contrarian oscillators 50.
News sentiment is neutral at 53; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 36 to 64, and it is down 25 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward BEAM’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
40Pulling it up
- Fair Value100
Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
Holding it back
- Earnings Profitability (Quarterly)0
Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.
- Earnings Quality (Annual)0
Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
39 weighted scorers; 2 had no data today and are left out rather than counted as zero.
Technical · daily
34Pulling it up
- Candlestick Patterns100
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
- ADX (14)71
Average Directional Index (ADX) measures trend strength regardless of direction.
- Bollinger Bands (50)67
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
Holding it back
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 200 Cross Up4
SMA 200 Cross Up tracks when faster moving averages cross above the 200-period SMA.
- SMA 100 Cross Up4
SMA 100 Cross Up identifies when shorter averages cross above the 100-period SMA.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 53
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 50 | 1 |
| Daily | 34 | 3 |
| Weekly | 30 | 2 |
| Monthly | 41 | 2 |
| Quarterly | 40 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 39 |
| Oct 21, 2026 | 40 |
| Oct 20, 2026 | 38 |
| Oct 19, 2026 | 37 |
| Oct 18, 2026 | 37 |
| Oct 17, 2026 | 37 |
| Oct 16, 2026 | 36 |
| Oct 15, 2026 | 39 |
| Oct 14, 2026 | 36 |
| Oct 13, 2026 | 39 |
| Oct 12, 2026 | 40 |
| Oct 11, 2026 | 42 |
| Oct 10, 2026 | 42 |
| Oct 9, 2026 | 41 |
| Oct 8, 2026 | 37 |
| Oct 7, 2026 | 39 |
| Oct 6, 2026 | 43 |
| Oct 5, 2026 | 41 |
| Oct 4, 2026 | 39 |
| Oct 3, 2026 | 39 |
| Oct 2, 2026 | 39 |
| Oct 1, 2026 | 38 |
| Sep 30, 2026 | 39 |
| Sep 29, 2026 | 38 |
| Sep 28, 2026 | 37 |
| Sep 27, 2026 | 38 |
| Sep 26, 2026 | 38 |
| Sep 25, 2026 | 38 |
| Sep 24, 2026 | 39 |
| Sep 23, 2026 | 39 |
| Sep 22, 2026 | 41 |
| Sep 21, 2026 | 40 |
| Sep 20, 2026 | 39 |
| Sep 19, 2026 | 39 |
| Sep 18, 2026 | 38 |
| Sep 17, 2026 | 39 |
| Sep 16, 2026 | 36 |
| Sep 15, 2026 | 36 |
| Sep 14, 2026 | 38 |
| Sep 13, 2026 | 37 |
| Sep 12, 2026 | 37 |
| Sep 11, 2026 | 37 |
| Sep 10, 2026 | 37 |
| Sep 9, 2026 | 39 |
| Sep 8, 2026 | 42 |
| Sep 7, 2026 | 50 |
| Sep 6, 2026 | 51 |
| Sep 5, 2026 | 51 |
| Sep 4, 2026 | 50 |
| Sep 3, 2026 | 50 |
| Sep 2, 2026 | 49 |
| Sep 1, 2026 | 49 |
| Aug 31, 2026 | 49 |
| Aug 30, 2026 | 49 |
| Aug 29, 2026 | 49 |
| Aug 28, 2026 | 49 |
| Aug 27, 2026 | 51 |
| Aug 26, 2026 | 52 |
| Aug 25, 2026 | 52 |
| Aug 24, 2026 | 48 |
| Aug 23, 2026 | 51 |
| Aug 22, 2026 | 51 |
| Aug 20, 2026 | 51 |
| Aug 19, 2026 | 52 |
| Aug 18, 2026 | 45 |
| Aug 17, 2026 | 47 |
| Aug 16, 2026 | 46 |
| Aug 15, 2026 | 47 |
| Aug 14, 2026 | 45 |
| Aug 13, 2026 | 47 |
| Aug 12, 2026 | 46 |
| Aug 11, 2026 | 46 |
| Aug 10, 2026 | 49 |
| Aug 9, 2026 | 50 |
| Aug 8, 2026 | 49 |
| Aug 7, 2026 | 49 |
| Aug 6, 2026 | 48 |
| Aug 5, 2026 | 49 |
| Aug 3, 2026 | 46 |
| Aug 2, 2026 | 45 |
| Jul 31, 2026 | 47 |
| Jul 30, 2026 | 48 |
| Jul 29, 2026 | 48 |
| Jul 28, 2026 | 64 |
| Jul 27, 2026 | 63 |
| Jul 26, 2026 | 63 |
| Jul 25, 2026 | 64 |
Key facts
- Market cap
- $2.5B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 2.20
- Risk grade (1–10)
- 7
- Next earnings
- Nov 3, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| MRVI Maravai LifeSciences | $2.6B | 44 |
| VRDN Viridian Therapeutics | $2.6B | 48 |
| NAMS NewAmsterdam Pharma Company | $2.5B | 39 |
| ZLAB Zai Lab | $2.5B | 37 |
| ADMA ADMA Biologics | $2.5B | 62 |
| RCUS Arcus Biosciences | $2.4B | 36 |
Questions
What is BEAM's stock score today?
BEAM scores 39/100 (Bearish) as of Oct 22, 2026: technical 38, fundamental 40, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.
Is BEAM a buy?
The score is not a buy or sell recommendation. A 39 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the BEAM score calculated?
101 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.